On April 3, 2024, George Ng, CEO of Processa Pharmaceuticals, Inc., presented at the MedInvest Biotech + Pharma Investor Conference in New York City. The presentation, titled 'Next Generation Chemotherapy: Improved Treatment for More Patients,' was delivered at 10:55 AM ET and was attended virtually by Dr. David Young, President of R&D. The presentation materials were uploaded to a portal and furnished as Exhibit 99.1, which is incorporated by reference. Additionally, the presentation will be accessible in the 'Investors' section of Processa's website. The company has stated that it has no obligation to update the information presented, but may do so through various means of public disclosure. Processa uses its website to disclose material non-public information in compliance with Regulation FD.

On April 3, 2024, George Ng, CEO of Processa Pharmaceuticals, Inc., presented at the MedInvest Biotech + Pharma Investor Conference in New York City. The presentation, titled 'Next Generation Chemotherapy: Improved Treatment for More Patients,' was delivered at 10:55 AM ET and was attended virtually by Dr. David Young, President of R&D. The presentation materials were uploaded to a portal and furnished as Exhibit 99.1, which is incorporated by reference. Additionally, the presentation will be accessible in the 'Investors' section of Processa's website. The company has stated that it has no obligation to update the information presented, but may do so through various means of public disclosure. Processa uses its website to disclose material non-public information in compliance with Regulation FD.